Involuntary smoking and head and neck cancer risk: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

Although active tobacco smoking has been identified as a major risk factor for head and neck cancer, involuntary smoking has not been adequately evaluated because of the relatively low statistical power in previous studies. We took advantage of data pooled in the International Head and Neck Cancer Epidemiology Consortium to evaluate the role of involuntary smoking in head and neck carcinogenesis. Involuntary smoking exposure data were pooled across six case-control studies in Central Europe, Latin America, and the United States. Adjusted odds ratios (OR) and 95% confidence interval (95% CI) were estimated for 542 cases and 2,197 controls who reported never using tobacco, and the heterogeneity among the study-specific ORs was assessed. In addition, stratified analyses were done by subsite. No effect of ever involuntary smoking exposure either at home or at work was observed for head and neck cancer overall. However, long duration of involuntary smoking exposure at home and at work was associated with an increased risk (OR for >15 years at home, 1.60; 95% CI, 1.12-2.28; P(trend) <0-01; OR for >15 years at work, 1.55; 95% CI, 1.04-2.30; P(trend) = 0.13). The effect of duration of involuntary smoking exposure at home was stronger for pharyngeal and laryngeal cancers than for other subsites. An association between involuntary smoking exposure and the risk of head and neck cancer, particularly pharyngeal and laryngeal cancers, was observed for long duration of exposure. These results are consistent with those for active smoking and suggest that elimination of involuntary smoking exposure might reduce head and neck cancer risk among never smokers.

National Institute of Health (NIH)

National Cancer Institute (NCI/NIH)[R03CA113157]

Central Europe study World Cancer Research Fund and European Commission`s I Program[IC15-CT98-0332]

National Cancer Institute and National Institute of Dental and Craniofacial Research intramural programs (NIH)

Latin America study : Fondo para la Investigacion Cientifi ca y Tecnologica (FONCyT) (Argentina)

Institut Municipal d`Invesigacio Medica (Barcelona)

FAPESP Fundação de Amparo à Pesquisa do Estado de São Paulo[01/01768-2]

European Commission[IC18-CT97-0222]

NIH[P01CA068384]

NIH[K07CA104231]

NIH[P50CA90388]

NIH[R01DA11386]

NIH[R03CA77954]

NIH[T32CA09142]

NIH[U01CA96134]

NIH[R21ES011667]

NIH[R01ES11740]

NIH[R01CA100264]

Alper Research Program tor Environmental Genomics of the University of California-Los Angeles Jonsson Comprehensive Cancer Center